Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2025 09:00 ET | Source: Bay Area Lyme Foundation

Journal of Clinical Microbiology Studies Demonstrate Two Investigational Diagnostics Outperform Current Tests in Detecting Early Lyme Disease

PORTOLA VALLEY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, the leading nonprofit funder of Lyme disease research in the US, today announced results from two independent...
October 09, 2025 07:04 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study

60 Degrees Pharma unveils “B-FREE” Phase 2 trial for chronic babesiosis, engaging patients in naming and supporting Lyme research groups.
October 01, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight

New York, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Lyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight According to DelveInsight’s analysis,...
September 04, 2025 11:00 ET | Source: Bay Area Lyme Foundation

Bay Area Lyme Foundation Launches Bay Area Lyme Ventures as First Impact Investment Fund to Support Entrepreneurs and Companies Advancing Lyme Disease Solutions

PORTOLA VALLEY, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the launch of Bay Area Lyme Ventures (Lyme...
July 17, 2025 08:01 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria

60 Degrees and Tulane to study tafenoquine against Lyme and Bartonella bacteria, part of the “3Bs” common in tick-borne illness co-infections.
July 10, 2025 03:00 ET | Source: Bay Area Lyme Foundation

New Bay Area Lyme Foundation Study Reports That Only One-Third of Early Lyme Patients with On-Going Symptoms Followed up with their Healthcare Providers

The new research, published in Frontiers in Medicine, points to the need for greater follow-up from medical professionals to address potential treatment failures. PORTOLA VALLEY, Calif., July 10,...
June 18, 2025 11:00 ET | Source: Bay Area Lyme Foundation

Bay Area Lyme Foundation Announces New Executive Director Josh Wein

PORTOLA VALLEY, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, has hired Josh Wein to serve as its new executive director,...
June 12, 2025 11:05 ET | Source: Bay Area Lyme Foundation

Bay Area Lyme Foundation Announces National Winner of the 2025 Emerging Leader Award to Develop a Much-Needed Rapid, Low-Cost, Easy-to-Use Lyme Disease Test

PORTOLA VALLEY, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, has given its 2025 Emerging Leader Award (ELA) to Chao Wang,...
June 11, 2025 10:00 ET | Source: Clinical and Laboratory Standards Institute

CLSI partners with LymeX Diagnostics Prize to support Phase 4 team advancing Lyme disease diagnostics

Clinical & Laboratory Standards Institute is partnering with LymeX Diagnostics Prize to accelerate the development of Lyme disease detection and treatment.
April 23, 2025 14:00 ET | Source: Bay Area Lyme Foundation

Science Translational Medicine Study Funded by the Bay Area Lyme Foundation Identifies FDA-approved Piperacillin as More Effective, Targeted Treatment for Lyme Disease

PORTOLA VALLEY, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, announces two pre-clinical studies published in the...